Locations:
Min Investment:
Max Investment:
Target Investment:
(2003 - 2007)
Total Funding: $50M
Total Funding: $73M
Total Funding: $5M
Total Funding: $4M
Total Funding: $6M
Total Funding: $4M
Total Funding: $3M
Total Funding: $7.3M
Total Funding: $7M
Total Funding: $12M
2018
2018
Building a simulation platform for crypto networks to help developers understand how decisions about security, governance, and consensus mechanisms are likely to affect network activity and asset value Backers include Paradigm, Coinbase, Distributed Global, Dragonfly, First Round, IA, and Polychain
2020
2020
2016 - 2018
2016 - 2018
High-frequency trading
2011 - 2016
2011 - 2016
2007 - 2011
2009 - 2011
Derived the energy spectrum and eigenfunctions for a Gauge/Gravity Duality model of charged black holes. These models help ease computations related to the certain models of high-temperature superconductors and other applications dependent on critical phase transitions. In the process, I found a new explicit example of a Generalized Sasaki-Einstein Metric.
2007 - 2011
2010 - 2010
I developed software to run multiple particle tracking simulations for the Cornell High Energy Synchrotron Source (CHESS) using Python and Fortran
2010 - 2010
2010 - 2010
Designed and implemented a testing framework in Python to provide quality assurance on multiple integration schemes used in Cornell's particle tracking simulation software.
2009 - 2009
2009 - 2009
The goal of this internship was to perform useful translational work that spanned both the bioinformatics and research-oriented areas of AstraZeneca's Wilmington R&D as well as the Clinical Development area. Projects Completed include: - Developing a drug-database search engine that worked with eRoom (coding done in ASP, VBA and occasionally Scala) - Evaluating psychological trials using mathematical techniques (mainly the use of finite probability measures on somewhat ordered clinical psychology data)
2008 - 2008
2008 - 2008
This job consisted of both lab and computational work at AstraZeneca Pharmaceuticals in Wilmington, Delaware. I worked on testing novel lipid drug-delivery systems, in particular self-microemulsifying drug delivery systems (SMEDDS). The work completed includes: - Testing of various SMEDDS compounds as vehicles for emerging psychology research compounds